We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+11.96%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$445M
AUM Growth
+$51.4M
Cap. Flow
+$26.8M
Cap. Flow %
6.02%
Top 10 Hldgs %
13.28%
Holding
846
New
291
Increased
146
Reduced
137
Closed
271

Top Buys

Rank Stock Value
1
KR icon
Kroger
KR
+$8.18M
2
ACN icon
Accenture
ACN
+$8.18M
3
GIS icon
General Mills
GIS
+$7.58M
4
LULU icon
lululemon athletica
LULU
+$5.81M
5
BBBY
Bed Bath & Beyond Inc
BBBY
+$4.82M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.7%
2 Technology 21.58%
3 Industrials 13.12%
4 Healthcare 11.03%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRG icon
76
NRG Energy
NRG
$28.7B
$1.42M 0.32%
46,200
+33,800
+273% +$1.09M
TAL icon
77
TAL Education Group
TAL
$5.9B
$1.41M 0.32%
38,300
+9,600
+33% +$377K
ZBRA icon
78
Zebra Technologies
ZBRA
$12.6B
$1.39M 0.31%
9,700
+1,900
+24% +$280K
EMN icon
79
Eastman Chemical
EMN
$7.74B
$1.35M 0.3%
+13,500
New +$1.43M
AZPN
80
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$1.34M 0.3%
+14,500
New +$1.34M
BALL icon
81
Ball Corp
BALL
$17.3B
$1.34M 0.3%
37,600
-13,900
-27% -$532K
PVH icon
82
PVH
PVH
$3.81B
$1.33M 0.3%
8,900
+716
+9% +$113K
J icon
83
Jacobs Solutions
J
$15.9B
$1.32M 0.3%
+25,103
New +$1.29M
HAE icon
84
Haemonetics
HAE
$3.65B
$1.31M 0.3%
14,654
+5,654
+63% +$477K
DHR icon
85
Danaher
DHR
$137B
$1.31M 0.29%
+14,966
New +$1.33M
SCHW
86
Charles Schwab
SCHW
$181B
$1.3M 0.29%
25,500
+19,200
+305% +$1.06M
DKS icon
87
Dick's Sporting Goods
DKS
$18.4B
$1.29M 0.29%
+36,500
New +$1.24M
MED icon
88
Medifast
MED
$109M
$1.28M 0.29%
7,992
+5,382
+206% +$688K
MET icon
89
MetLife
MET
$61.3B
$1.27M 0.29%
+29,200
New +$1.36M
PLAY icon
90
Dave & Buster's
PLAY
$360M
$1.24M 0.28%
+25,957
New +$1.15M
ZEN
91
DELISTED
ZENDESK INC
ZEN
$1.24M 0.28%
22,674
+500
+2% +$26.6K
RMD icon
92
ResMed
RMD
$29.4B
$1.23M 0.28%
11,874
+1,300
+12% +$132K
LITE icon
93
Lumentum
LITE
$55.9B
$1.23M 0.28%
21,200
+3,200
+18% +$191K
COO icon
94
Cooper Companies
COO
$13.8B
$1.21M 0.27%
+20,512
New +$1.17M
PTC icon
95
PTC
PTC
$14.5B
$1.21M 0.27%
12,856
+5,325
+71% +$460K
RHI icon
96
Robert Half
RHI
$4.04B
$1.19M 0.27%
18,329
+8,800
+92% +$558K
CTXS
97
DELISTED
Citrix Systems Inc
CTXS
$1.19M 0.27%
+11,335
New +$1.17M
RP
98
DELISTED
RealPage, Inc.
RP
$1.18M 0.27%
21,465
+11,800
+122% +$666K
SIX
99
DELISTED
Six Flags Entertainment Corp.
SIX
$1.17M 0.26%
+16,704
New +$1.09M
ILMN icon
100
Illumina
ILMN
$28.8B
$1.16M 0.26%
+4,279
New +$1.09M

Similar funds

Bayesian Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bayesian Capital Management held 846 positions worth $445M, up 13% from $393M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Bayesian Capital Management deployed $26.8M of net new capital in Q2 2018, opening 291 new positions and adding to 146 existing holdings. Its largest new stake was Kroger: 325,365 shares worth $9.26M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $14.8M trimmed.

  • Bayesian Capital Management's largest Q2 2018 buy was Kroger: 325,365 shares worth $9.26M.
  • Bayesian Capital Management added most to Burlington in Q2 2018, an estimated $3.26M increase.
  • Bayesian Capital Management's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $14.8M.
  • Bayesian Capital Management fully exited Nike in Q2 2018, selling an estimated $3.43M.
  • Bayesian Capital Management's ten largest holdings make up 13% of its $445M portfolio in Q2 2018.
  • Bayesian Capital Management opened 291 new positions and closed 271 in Q2 2018.
  • Bayesian Capital Management's portfolio value rose 13% quarter-over-quarter to $445M.

Based on Bayesian Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.